Silver Book Fact

Using technologies as treatment for heart disease helps generate cost savings, including a total of $1930 annual savings per person, and a $1.5 billion increased tax revenue

Chatterjee A, King J, Kubendran S, DeVol R. Healthy Savings: Medical technology and the economic burden of disease. Santa Monica, CA: Milken Institute; 2014:15. http://lifechanginginnovation.org/sites/default/files/files/HealthySavingsFinal(1).pdf. Accessed November 3, 2015

Reference

Title
Healthy Savings: Medical technology and the economic burden of disease
Publisher
Milken Institute
Publication Date
2014
Authors
Chatterjee A, King J, Kubendran S, DeVol R
Pages
15
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • A calculated approximate benefit-to-cost ratio for antihypertensive therapy is 10:1 for men and 6:1 for women.  
  • Medicines in Development for Heart Disease and Stroke, 2008  
  • Increased use of non-acute medications in primary and secondary prevention explains about 1/3 of the total reduction in cardiovascular disease mortality since 1950.  
  • “Sherri Selph was 41 when she was first diagnosed with second-stage congestive heart failure. However, her rapidly diminishing health led to a diagnosis of end-stage heart disease. A heart transplant…  
  • The greater use of medications and revascularization would provide approximately a 17% reduction in 2 year mortality combined.